Thomas A. Ciulla

Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor

Lloyd Paul Aiello, Sven-Erik Bursell, Allen C. Clermont et al. · Diabetes · 1997 · 664 citations

Ocular Disease, Retinal Therapies, Vascular Permeability +18

Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

Quan Dong Nguyen, Syed Mahmood Shah, Afsheen Khwaja et al. · Ophthalmology · 2010 · 529 citations

Metabolic Syndrome, Diabetes Management, Diabetes +4

Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema

Peter A. Campochiaro, David M. Brown, Andrew Pearson et al. · Ophthalmology · 2011 · 398 citations

Ocular Disease, Vitreous Body, Ophthalmology +4

INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Ronald P. Danis, Thomas A. Ciulla, WAYNE ANLIKER LINDA M. PRATT · Retina · 2000 · 381 citations

Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration

Jeffrey S. Heier, Andrew N. Antoszyk, Peter R. Pavan et al. · Ophthalmology · 2006 · 361 citations

Ocular Disease, Ophthalmology, Age-related Diseases +2